| Market Cap | ₹110.44 CrHealthcare Services |
|---|---|
| P/E TTM | 5.73Sector PE 56.58 |
| Promoter Holding | 71.92%Latest Quarter |
| 1-Year Return | -54.02%Price Performance |
| Execution period | Valid up to 31 December 2027 |
Key highlights
- MoU signed with BSES Yamuna Power Limited (BYPL) for designated diagnostic centre status
- Scope includes pathology and radiology diagnostic services for employees and family members
- Agreement remains valid until December 31, 2027
- Services to be provided at prevailing CGHS rates on both credit and cash basis
- Company currently operates with a market capitalization of ₹110.44 crore
Diagnostic Empanelment and Service Scope
Star Imaging and Path Lab Limited formally announced the execution of a Memorandum of Understanding (MoU) with BSES Yamuna Power Limited (BYPL) on November 17, 2026. Under this arrangement, the company will act as a designated diagnostic centre, providing a comprehensive suite of pathology and radiology services. The agreement specifically caters to BYPL employees, their eligible dependent family members, and other designated beneficiaries.
The MoU is structured to remain in effect until December 31, 2027, with services priced according to prevailing Central Government Health Scheme (CGHS) rates. This partnership is expected to bolster the company's network and diversify its institutional client base.
Strategic Growth Through Institutional Tie-ups
- Secured diagnostic empanelment with the Municipal Corporation of Delhi (MCD) on October 12, 2026
- Entered diagnostic services agreement with Delhi High Court on January 21, 2026
- Signed empanelment MoUs with Bureau of Indian Standards and IPGCL in February 2026
- Commissioning of the new Dwarka diagnostic centre scheduled for end-November 2026
- Ongoing execution of three advanced diagnostic projects involving MRI and CT modalities
- Strategic focus on credit-based institutional services at standard government-prescribed rates
Financial Performance and Market Position
The company reported an annual net profit of ₹19.28 crore for the year ending March 2026, representing a year-on-year growth of 21.06%. While the stock has experienced significant volatility with a one-year price decline of 54.02%, its valuation metrics remain distinct within the healthcare services sector. Specifically, the company's price-to-earnings (P/E) ratio stands at 5.73, compared to the industry average of 44.94.
With a high promoter holding of 71.92% and zero reported pledges, the company maintains a stable ownership structure as it prepares for its H1 FY27 earnings call scheduled for November 18, 2026.
| Date | Announcement | Amount |
|---|---|---|
| 12 Oct 2026 | Empanelment agreement with Municipal Corporation of Delhi (MCD) to provide diagnostic services at CGHS prescribed ratesSource: scanx.trade | – |
| 09 Feb 2026 | Empanelment agreement with Bureau of Indian Standards (BIS) and Indraprastha Power Generation Company Limited (IPGCL) for diagnostic servicesSource: shreni.in | – |
| 22 Jan 2026 | Empanelment agreement with National Institute of Educational Planning and Administration (NIEPA) for medical diagnostic and laboratory servicesSource: economictimes.indiatimes.com | – |
| 21 Jan 2026 | Agreement with High Court of Delhi to provide credit and cashless medical diagnostic servicesSource: scanx.trade | – |
| 14 Jan 2026 | Empanelment agreement with Central Electricity Regulatory Commission (CERC) for medical diagnostic and laboratory servicesSource: scanx.trade | – |
| 13 Jan 2026 | Empanelment agreement with Indian Council of Social Science Research (ICSSR), Ministry of Education, for diagnostic servicesSource: shreni.in | – |
What to watch next
- H1 FY27 earnings conference call scheduled for November 18, 2026
- Operational commissioning of the Dwarka diagnostic centre by late November 2026
- Progress on three advanced diagnostic projects featuring high-end imaging technology
| Share price | ₹63.4 |
|---|---|
| Market capitalisation | ₹110.44 Cr |
| Revenue (annual) | ₹88.53 Cr |
| Net profit (annual) | ₹19.28 Cr |
| P/E (TTM) | 5.73×Sector 56.58× |
| Promoter holding | 71.92% |
| FII holding | 0.06%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Star Imaging and Path Lab Limited regarding the execution of an MoU with BSES Yamuna Power Limited. Market figures from a third-party data provider.



